CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. CLINICAL TRIALS
3.4. GOVERNMENTAL REGULATIONS

3.4.1. FDA
3.4.2. Health Canada
3.4.3. CE Mark
3.4.4. Ministry of Health, Labour and Welfare (MHLW)
3.4.5. Therapeutic Goods Administration (TGA)

3.5. REIMBURSEMENT SCENARIO

3.5.1. U.S.
3.5.2. Canada
3.5.3. Germany
3.5.4. UK
3.5.5. Italy
3.5.6. Japan

3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Growth in geriatric population
3.6.1.2. Increase in smoking population
3.6.1.3. Technological advancements
3.6.1.4. Favorable reimbursements

3.6.2. Restraints

3.6.2.1. High cost and risk associated with the procedure
3.6.2.2. Lack of awareness in developing region

3.6.3. Opportunities

3.6.3.1. Increase in awareness of AAA
3.6.3.2. Lucrative opportunities in emerging economies

CHAPTER 4 ABDOMINAL AORTIC ANEURYSM REPAIR DEVICES MARKET, BY PRODUCT TYPE

4.1. OVERVIEW
4.2. MARKET SIZE AND FORECAST
4.3. ENDOVASCULAR STENT GRAFT SYSTEM

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. SYNTHETIC GRAFT SYSTEM

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

CHAPTER 5 ABDOMINAL AORTIC ANEURYSM REPAIR DEVICES MARKET, BY ANATOMY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. TRADITIONAL ANATOMY

5.2.1. Market size and forecast

5.3. COMPLEX ANATOMY

5.3.1. Market size and forecast

CHAPTER 6 ABDOMINAL AORTIC ANEURYSM REPAIR DEVICES MARKET, BY SITE

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. INFRARENAL AAA

6.2.1. Market size and forecast

6.3. PARARENAL AAA

6.3.1. Market size and forecast
6.3.2. Juxtarenal AAA

6.3.2.1. Market size and forecast

6.3.3. Suprarenal Site

6.3.3.1. Market size and forecast

CHAPTER 7 ABDOMINAL AORTIC ANEURYSM REPAIR DEVICES MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany market size and forecast
7.3.5. France market size and forecast
7.3.6. UK market size and forecast
7.3.7. Italy market size and forecast
7.3.8. Spain market size and forecast
7.3.9. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan market size and forecast
7.4.5. China market size and forecast
7.4.6. Australia market size and forecast
7.4.7. India market size and forecast
7.4.8. South Korea market size and forecast
7.4.9. Thailand market size and forecast
7.4.10. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil market size and forecast
7.5.5. Turkey market size and forecast
7.5.6. Saudi Arabia market size and forecast
7.5.7. Republic of South Africa market size and forecast
7.5.8. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. CARDIATIS S.A.

8.1.1. Company overview
8.1.2. Operating business segments
8.1.3. Business performance

8.2. CARDINAL HEALTH, INC.

8.2.1. Company overview
8.2.2. Operating business segments
8.2.3. Business performance
8.2.4. Key strategic moves and developments

8.3. COOK MEDICAL, INC.

8.3.1. Company overview
8.3.2. Operating business segments
8.3.3. Business performance
8.3.4. Key strategic moves and developments

8.4. ENDOLOGIX, INC.

8.4.1. Company overview
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. JOTEC GMBH

8.5.1. Company overview
8.5.2. Operating business segments
8.5.3. Business performance

8.6. LOMBARD MEDICAL, INC.

8.6.1. Company overview
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. MEDTRONIC PLC

8.7.1. Company overview
8.7.2. Operating business segments
8.7.3. Business performance
8.7.4. Key strategic moves and developments

8.8. NANO ENDOLUMINAL

8.8.1. Company overview
8.8.2. Business performance

8.9. TERUMO CORPORATION

8.9.1. Company overview
8.9.2. Operating business segments
8.9.3. Business performance
8.9.4. Key strategic moves and developments

8.10. W. L. GORE & ASSOCIATES, INC.

8.10.1. Company overview
8.10.2. Operating business segments
8.10.3. Business Performance
8.10.4. Key strategic moves and developments